Skip to main content
CD Laboratory for Chemical Epigenetics and Antiinfectives
FFG Bridge "ImmunoDegraders"
FWF International I4768 "Resetting the Epigenetic Status of the DM1Locus"
FWF Clinical Research 1056 "ExTrAct AML"
FWF International I5133 "Discovery of chemotherapeutic lead-compounds in cynobacteria"
FWF SFB F 6102-B21 "Chromatin Landscapes"
FWF SFB F 7002-B21 "HDACs as regulators of T cell-mediated immunity in health and disease"
FWF SFB F 7909-B "Chemical probing and functional characterization of the E3 substrate receptor DCAF15"
FWF Stand-Alone P 35701
FWF Stand-Alone P 32125-B
FWF Stand-Alone P 31690-B28
FWF START Y1037
OeAW New Frontier Group 2013
OeAW NFRI 2015
OeAW Innovationsfonds "KRAScondensate"
WWTF LS18 - 058 "Systems medicine analysis of sarcoidosis by targeting mTOR in a co-clinical trial in patients and mice"
WWTF LS18 - 049 "Characterizing and targeting the Ewing sarcoma microenvironment to overcome resistance to therapy"
WWTF LS20 - 034 "Decoding cellular senescence in glioblastoma"
WWTF LS20 - 045 "LiquidBiopsyKids: Validation of a liquid biopsy based molecular diagnostic toolkit for pediatric sarcomas"
WWTF LS20 - 065 "PREDICTOME: Precision medicine for breast cancer: multi-omics towards predicting complete remission and avoiding surgery"
WWTF LS21 - 010 "Mechanistic target elucidation by systematic stochastic tagging of antiproliferative compounds"
WWTF LS21 - 015 "ReprogrammAR: Chemical Reprogramming of Autophagy Receptors"
FFG Bridge Program 2019
Duration 2019 - 2022
Georg Winter's Group
Innovating Strategies to prompt anti-cancer immunity via targeted protein degradation